Chronic Gout – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Gout is a disorder of purine metabolism that causes hyperuricemia and generally refers to a form of arthritis. The first symptoms include intense pain in only one hallux joint in 90% of the cases. The elevated blood uric acid level in men (serum-urate level >7 mg/dl) and in women (serum-urate level >6) results in the formation of monosodium urate (MSU) crystals and deposition in joint bones and subcutaneous tissue. Hyperuricemia is not the only factor for gout. Other factors are also implicated in gouts, such as age, gender, obesity, alcohol consumption, medication, comorbid disease, genetics, and purine diet. Hyperuricaemia and gout can be considered over four pathological stages: development of hyperuricemia, deposition of monosodium urate crystals, the clinical presentation of gout flares due to an acute inflammatory response to deposited crystals, and clinical presentation of an advanced disease characterized by tophi. The estimated prevalence of gout in U.S. a...